Studies find combination chemotherapy beneficial and cost-effective in sub-Saharan Africa

Researchers at the UNC Lineberger Comprehensive Cancer Center demonstrated in a clinical trial in Malawi that a five-drug combination chemotherapy provided curative benefit compared to current standard-of care-therapy in people diagnosed with lymphoma, and now they have determined this option is also cost-effective. The economic finding appeared July 22, 2021, in Lancet Global Health.

source https://medicalxpress.com/news/2021-07-combination-chemotherapy-beneficial-cost-effective-sub-saharan.html